|
|
42
|
|
|
A101L
|
|
|
LABETALOL 5MG/ML INJ (MON)
|
|
|
LABETALOL
|
|
|
LABETALOL
|
|
|
20ML
|
|
|
B
|
|
|
4.65
|
|
|
4.65
|
|
|
5MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
MON
|
|
|
MONTAGE PHARMACEUTICALS
|
|
|
PHA
|
|
|
PHARMACY SALES CARIBBEAN
|
|
|
|
|
|
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
2424
|
|
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|